Patent · US Active

Fused antigen vaccines and compositions against Streptococcus pneumoniae

US9765125B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignees

Genocea Biosciences, Inc. · US
Children's Medical Center Corporation · US

Inventors

Jessica Flechtner · Maynard, US
Richard Malley · Beverly, US

Key dates

Filing date	Jan 18, 2013
Grant date	Sep 19, 2017
Priority date	—
Expiry date	Jan 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae that contain fusion proteins. The antigens may be used therapeutically or prophylactically.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.